Skip to main content
Fig. 4 | Diagnostic Pathology

Fig. 4

From: Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms

Fig. 4

Mutation status matrix across 50 patient samples and 54 genes. Patients (initial samples only, if applicable) and genes are arranged in columns and rows, respectively. Seventy-seven detectable mutations in 24 genes are represented by colored boxes (green, yellow and red for 1, 2, and 3 mutations, respectively). Patient samples with known complex and unfavorable cytogenetics are shaded in black.

Back to article page